04/17/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/04/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:07 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:56 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
5:03 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:33 PM | Olian Judy D. (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Klein Katherine J (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:52 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:50 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:03 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:31 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
5:03 AM | United Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:36 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:57 PM | ROTHBLATT MARTINE A (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
8:05 AM | Avoro Capital Advisors LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:50 AM | RENAISSANCE TECHNOLOGIES LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
02/08/2024
9:18 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024
5:00 AM | Celularity Inc (Subject)
Celularity Inc (Subject)
United Therapeutics (Filed by)
| Form SC 13G/A | |
02/02/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:29 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
01/18/2024
4:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:12 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:51 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC 13D | |
12/21/2023
3:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:00 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:53 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:40 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
1:06 PM | Miromatrix Medical Inc. (Issuer)
United Therapeutics (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2023
4:29 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
9:03 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/12/2023
3:37 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
9:52 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/07/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
5:00 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:01 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
5:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T | |
11/08/2023
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
4:24 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:50 PM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
11/01/2023
5:03 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
6:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
10/30/2023
6:09 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
10/20/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2023
4:54 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
4:12 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
4:53 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:19 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:11 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
08/02/2023
5:02 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
5:08 AM | United Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/24/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:30 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
5:30 AM | Klein Katherine J (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:30 AM | KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:30 AM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:30 AM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
